INS and type 1 diabetes mellitus: The increased risk of hypoglycaemia seen with once‐weekly versus once‐daily basal insulins in type 1 diabetes may plausibly reflect an interplay between pharmacological features of once‐weekly formulations and protocol‐driven titration approaches.